Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy
📧 Sign up to get email alerts when something new happens for Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Natural History of Individuals With Immune System Problems That Lead to Fungal Infections
This clinical trial update notes ongoing recruitment for a natural history study of individuals with immune system defects that predispose t…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Evaluation Genotypic, Phenotypic and Prognosis APECED Syndrome
Clinical trial update indicates completion of the study evaluating genotypic, phenotypic, and prognostic aspects of Autoimmune polyendocrino…
-
CLINICAL_TRIALS research · 2025-12-11Clinical Trial Update: Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis [Phase 2]
Phase 2 randomized stepped-wedge trial evaluating emapalumab for enteritis in Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of ruxolitinib for hair regrowth in patients with Autoimmune Polyendocrinopat…